Loading…
Genetics and iron in the systems biology of Parkinson’s disease and some related disorders
► Multiple genes have been found to be associated with Parkinson’s disease. ► Much evidence shows that unliganded iron is also heavily involved. ► The gene products are involved in metabolic and signalling pathways. ► A systems biology approach allows one to account for these effectively. ► We there...
Saved in:
Published in: | Neurochemistry international 2013-04, Vol.62 (5), p.637-652 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c441t-bc477321fd5a5116782fd28a1d26f5f1f98829721dafb2a02e67695e4f70c55a3 |
---|---|
cites | cdi_FETCH-LOGICAL-c441t-bc477321fd5a5116782fd28a1d26f5f1f98829721dafb2a02e67695e4f70c55a3 |
container_end_page | 652 |
container_issue | 5 |
container_start_page | 637 |
container_title | Neurochemistry international |
container_volume | 62 |
creator | Funke, Claudia Schneider, Susanne A. Berg, Daniela Kell, Douglas B. |
description | ► Multiple genes have been found to be associated with Parkinson’s disease. ► Much evidence shows that unliganded iron is also heavily involved. ► The gene products are involved in metabolic and signalling pathways. ► A systems biology approach allows one to account for these effectively. ► We therefore provide a unifying explanation of disease development.
The systems biology approach to complex diseases recognises that a potentially large number of biochemical network elements may be involved in disease progression, especially where positive feedback loops can be identified. Most of these network elements will be encoded by genes, for which different alleles may affect the network(s) differentially. A primary requirement is therefore to determine the relevant gene-network relationships. A corollary of this is that identification of the network should thereby allow one to ‘explain’ or account for any genetic associations.
We apply this approach to Parkinson’s disease, a disease characterised by apoptotic death of neurons of the substantia nigra, and coupled significantly to a derangement of iron metabolism. We thereby account for the involvement of various genes and biochemical pathways associated with Parkinsonism, including seemingly unconnected ones involving iron, α-synuclein, parkin, mitochondrial respiration and biology, ceramide production, lysosome biology, Lewy body formation, and so on. Although such an analysis necessarily recognises that there is no unitary ‘cause’ of Parkinson’s, it also recognises that each of the elements contributing can or does effectively converge on a particular mode of apoptotic cell death in dopaminergic neurons, often involving iron-mediated hydroxyl radical formation.
Overall, the systems biology approach allows us to propose at least one coherent synthesis of the rather disparate literature surrounding the aetiology of Parkinson’s disease, and thereby to suggest some (synergistic) targets for ameliorating the disease and its progression. |
doi_str_mv | 10.1016/j.neuint.2012.11.015 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1322731153</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0197018612003889</els_id><sourcerecordid>1322731153</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-bc477321fd5a5116782fd28a1d26f5f1f98829721dafb2a02e67695e4f70c55a3</originalsourceid><addsrcrecordid>eNp9kMFu1DAQhi0EotvCG6DKRy5JPU4cJ5dKqCptpUrlADcky2uPwUtit55spb3xGrweT0KWbTlymsN8__yaj7F3IGoQ0J1t6oTbmOZaCpA1QC1AvWAr6LWsBq3al2wlYNCVgL47YsdEGyGEHoR6zY5kI6Vo-m7Fvl5hwjk64jZ5HktOPCY-f0dOO5pxIr6OeczfdjwH_smWHzFRTr9__iLuI6El_BukPCEvONoZ_X6Ri8dCb9irYEfCt0_zhH35ePn54rq6vbu6ufhwW7m2hblau1brRkLwyiqATvcyeNlb8LILKkAY-l4OWoK3YS2tkNjpblDYBi2cUrY5Ye8Pd-9LftgizWaK5HAcbcK8JQPLu7oBUM2CtgfUlUxUMJj7EidbdgaE2Xs1G3PwavZeDYBZvC6x06eG7XpC_y_0LHIBzg8ALn8-RiyGXMTk0MeCbjY-x_83_AGoBoxT</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1322731153</pqid></control><display><type>article</type><title>Genetics and iron in the systems biology of Parkinson’s disease and some related disorders</title><source>ScienceDirect Freedom Collection</source><creator>Funke, Claudia ; Schneider, Susanne A. ; Berg, Daniela ; Kell, Douglas B.</creator><creatorcontrib>Funke, Claudia ; Schneider, Susanne A. ; Berg, Daniela ; Kell, Douglas B.</creatorcontrib><description>► Multiple genes have been found to be associated with Parkinson’s disease. ► Much evidence shows that unliganded iron is also heavily involved. ► The gene products are involved in metabolic and signalling pathways. ► A systems biology approach allows one to account for these effectively. ► We therefore provide a unifying explanation of disease development.
The systems biology approach to complex diseases recognises that a potentially large number of biochemical network elements may be involved in disease progression, especially where positive feedback loops can be identified. Most of these network elements will be encoded by genes, for which different alleles may affect the network(s) differentially. A primary requirement is therefore to determine the relevant gene-network relationships. A corollary of this is that identification of the network should thereby allow one to ‘explain’ or account for any genetic associations.
We apply this approach to Parkinson’s disease, a disease characterised by apoptotic death of neurons of the substantia nigra, and coupled significantly to a derangement of iron metabolism. We thereby account for the involvement of various genes and biochemical pathways associated with Parkinsonism, including seemingly unconnected ones involving iron, α-synuclein, parkin, mitochondrial respiration and biology, ceramide production, lysosome biology, Lewy body formation, and so on. Although such an analysis necessarily recognises that there is no unitary ‘cause’ of Parkinson’s, it also recognises that each of the elements contributing can or does effectively converge on a particular mode of apoptotic cell death in dopaminergic neurons, often involving iron-mediated hydroxyl radical formation.
Overall, the systems biology approach allows us to propose at least one coherent synthesis of the rather disparate literature surrounding the aetiology of Parkinson’s disease, and thereby to suggest some (synergistic) targets for ameliorating the disease and its progression.</description><identifier>ISSN: 0197-0186</identifier><identifier>EISSN: 1872-9754</identifier><identifier>DOI: 10.1016/j.neuint.2012.11.015</identifier><identifier>PMID: 23220386</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Biocatalysis ; Brain - metabolism ; Cell Death ; GWAS ; Holistic analysis ; Humans ; Iron ; Iron - metabolism ; Organelles - metabolism ; PARK genes ; Parkinson Disease - genetics ; Parkinson Disease - metabolism ; Parkinson Disease - pathology ; Parkinson’s disease ; Systems Biology</subject><ispartof>Neurochemistry international, 2013-04, Vol.62 (5), p.637-652</ispartof><rights>2013 Elsevier Ltd</rights><rights>Copyright © 2013 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-bc477321fd5a5116782fd28a1d26f5f1f98829721dafb2a02e67695e4f70c55a3</citedby><cites>FETCH-LOGICAL-c441t-bc477321fd5a5116782fd28a1d26f5f1f98829721dafb2a02e67695e4f70c55a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23220386$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Funke, Claudia</creatorcontrib><creatorcontrib>Schneider, Susanne A.</creatorcontrib><creatorcontrib>Berg, Daniela</creatorcontrib><creatorcontrib>Kell, Douglas B.</creatorcontrib><title>Genetics and iron in the systems biology of Parkinson’s disease and some related disorders</title><title>Neurochemistry international</title><addtitle>Neurochem Int</addtitle><description>► Multiple genes have been found to be associated with Parkinson’s disease. ► Much evidence shows that unliganded iron is also heavily involved. ► The gene products are involved in metabolic and signalling pathways. ► A systems biology approach allows one to account for these effectively. ► We therefore provide a unifying explanation of disease development.
The systems biology approach to complex diseases recognises that a potentially large number of biochemical network elements may be involved in disease progression, especially where positive feedback loops can be identified. Most of these network elements will be encoded by genes, for which different alleles may affect the network(s) differentially. A primary requirement is therefore to determine the relevant gene-network relationships. A corollary of this is that identification of the network should thereby allow one to ‘explain’ or account for any genetic associations.
We apply this approach to Parkinson’s disease, a disease characterised by apoptotic death of neurons of the substantia nigra, and coupled significantly to a derangement of iron metabolism. We thereby account for the involvement of various genes and biochemical pathways associated with Parkinsonism, including seemingly unconnected ones involving iron, α-synuclein, parkin, mitochondrial respiration and biology, ceramide production, lysosome biology, Lewy body formation, and so on. Although such an analysis necessarily recognises that there is no unitary ‘cause’ of Parkinson’s, it also recognises that each of the elements contributing can or does effectively converge on a particular mode of apoptotic cell death in dopaminergic neurons, often involving iron-mediated hydroxyl radical formation.
Overall, the systems biology approach allows us to propose at least one coherent synthesis of the rather disparate literature surrounding the aetiology of Parkinson’s disease, and thereby to suggest some (synergistic) targets for ameliorating the disease and its progression.</description><subject>Biocatalysis</subject><subject>Brain - metabolism</subject><subject>Cell Death</subject><subject>GWAS</subject><subject>Holistic analysis</subject><subject>Humans</subject><subject>Iron</subject><subject>Iron - metabolism</subject><subject>Organelles - metabolism</subject><subject>PARK genes</subject><subject>Parkinson Disease - genetics</subject><subject>Parkinson Disease - metabolism</subject><subject>Parkinson Disease - pathology</subject><subject>Parkinson’s disease</subject><subject>Systems Biology</subject><issn>0197-0186</issn><issn>1872-9754</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNp9kMFu1DAQhi0EotvCG6DKRy5JPU4cJ5dKqCptpUrlADcky2uPwUtit55spb3xGrweT0KWbTlymsN8__yaj7F3IGoQ0J1t6oTbmOZaCpA1QC1AvWAr6LWsBq3al2wlYNCVgL47YsdEGyGEHoR6zY5kI6Vo-m7Fvl5hwjk64jZ5HktOPCY-f0dOO5pxIr6OeczfdjwH_smWHzFRTr9__iLuI6El_BukPCEvONoZ_X6Ri8dCb9irYEfCt0_zhH35ePn54rq6vbu6ufhwW7m2hblau1brRkLwyiqATvcyeNlb8LILKkAY-l4OWoK3YS2tkNjpblDYBi2cUrY5Ye8Pd-9LftgizWaK5HAcbcK8JQPLu7oBUM2CtgfUlUxUMJj7EidbdgaE2Xs1G3PwavZeDYBZvC6x06eG7XpC_y_0LHIBzg8ALn8-RiyGXMTk0MeCbjY-x_83_AGoBoxT</recordid><startdate>20130401</startdate><enddate>20130401</enddate><creator>Funke, Claudia</creator><creator>Schneider, Susanne A.</creator><creator>Berg, Daniela</creator><creator>Kell, Douglas B.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20130401</creationdate><title>Genetics and iron in the systems biology of Parkinson’s disease and some related disorders</title><author>Funke, Claudia ; Schneider, Susanne A. ; Berg, Daniela ; Kell, Douglas B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-bc477321fd5a5116782fd28a1d26f5f1f98829721dafb2a02e67695e4f70c55a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Biocatalysis</topic><topic>Brain - metabolism</topic><topic>Cell Death</topic><topic>GWAS</topic><topic>Holistic analysis</topic><topic>Humans</topic><topic>Iron</topic><topic>Iron - metabolism</topic><topic>Organelles - metabolism</topic><topic>PARK genes</topic><topic>Parkinson Disease - genetics</topic><topic>Parkinson Disease - metabolism</topic><topic>Parkinson Disease - pathology</topic><topic>Parkinson’s disease</topic><topic>Systems Biology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Funke, Claudia</creatorcontrib><creatorcontrib>Schneider, Susanne A.</creatorcontrib><creatorcontrib>Berg, Daniela</creatorcontrib><creatorcontrib>Kell, Douglas B.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neurochemistry international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Funke, Claudia</au><au>Schneider, Susanne A.</au><au>Berg, Daniela</au><au>Kell, Douglas B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Genetics and iron in the systems biology of Parkinson’s disease and some related disorders</atitle><jtitle>Neurochemistry international</jtitle><addtitle>Neurochem Int</addtitle><date>2013-04-01</date><risdate>2013</risdate><volume>62</volume><issue>5</issue><spage>637</spage><epage>652</epage><pages>637-652</pages><issn>0197-0186</issn><eissn>1872-9754</eissn><abstract>► Multiple genes have been found to be associated with Parkinson’s disease. ► Much evidence shows that unliganded iron is also heavily involved. ► The gene products are involved in metabolic and signalling pathways. ► A systems biology approach allows one to account for these effectively. ► We therefore provide a unifying explanation of disease development.
The systems biology approach to complex diseases recognises that a potentially large number of biochemical network elements may be involved in disease progression, especially where positive feedback loops can be identified. Most of these network elements will be encoded by genes, for which different alleles may affect the network(s) differentially. A primary requirement is therefore to determine the relevant gene-network relationships. A corollary of this is that identification of the network should thereby allow one to ‘explain’ or account for any genetic associations.
We apply this approach to Parkinson’s disease, a disease characterised by apoptotic death of neurons of the substantia nigra, and coupled significantly to a derangement of iron metabolism. We thereby account for the involvement of various genes and biochemical pathways associated with Parkinsonism, including seemingly unconnected ones involving iron, α-synuclein, parkin, mitochondrial respiration and biology, ceramide production, lysosome biology, Lewy body formation, and so on. Although such an analysis necessarily recognises that there is no unitary ‘cause’ of Parkinson’s, it also recognises that each of the elements contributing can or does effectively converge on a particular mode of apoptotic cell death in dopaminergic neurons, often involving iron-mediated hydroxyl radical formation.
Overall, the systems biology approach allows us to propose at least one coherent synthesis of the rather disparate literature surrounding the aetiology of Parkinson’s disease, and thereby to suggest some (synergistic) targets for ameliorating the disease and its progression.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>23220386</pmid><doi>10.1016/j.neuint.2012.11.015</doi><tpages>16</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0197-0186 |
ispartof | Neurochemistry international, 2013-04, Vol.62 (5), p.637-652 |
issn | 0197-0186 1872-9754 |
language | eng |
recordid | cdi_proquest_miscellaneous_1322731153 |
source | ScienceDirect Freedom Collection |
subjects | Biocatalysis Brain - metabolism Cell Death GWAS Holistic analysis Humans Iron Iron - metabolism Organelles - metabolism PARK genes Parkinson Disease - genetics Parkinson Disease - metabolism Parkinson Disease - pathology Parkinson’s disease Systems Biology |
title | Genetics and iron in the systems biology of Parkinson’s disease and some related disorders |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T17%3A38%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Genetics%20and%20iron%20in%20the%20systems%20biology%20of%20Parkinson%E2%80%99s%20disease%20and%20some%20related%20disorders&rft.jtitle=Neurochemistry%20international&rft.au=Funke,%20Claudia&rft.date=2013-04-01&rft.volume=62&rft.issue=5&rft.spage=637&rft.epage=652&rft.pages=637-652&rft.issn=0197-0186&rft.eissn=1872-9754&rft_id=info:doi/10.1016/j.neuint.2012.11.015&rft_dat=%3Cproquest_cross%3E1322731153%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c441t-bc477321fd5a5116782fd28a1d26f5f1f98829721dafb2a02e67695e4f70c55a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1322731153&rft_id=info:pmid/23220386&rfr_iscdi=true |